Fetal DNA in maternal plasma in preeclamptic pregnancies

References

• Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–7
   PubMed Web of Science ®Google Scholar
• Alberry M, Maddocks D, Jones M, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenatal Diagnosis 2007;27:415–18
   PubMed Web of Science ®Google Scholar
• Giacona MB, Ruben GC, Iczkowski KA, et al. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 1998;17:89–97
   PubMed Web of Science ®Google Scholar
• Chan KCA, Zhang J, Hui ABY, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50:88–92
   PubMed Web of Science ®Google Scholar
• Lo YMD, Tein MSC, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768–75
   PubMed Web of Science ®Google Scholar
• Lun FMF, Chiu RWK, Chan KCA, et al. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008;54:1664–72
   PubMed Web of Science ®Google Scholar
• Lo YMD, Chan KCA, Sun H, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Translational Med 2010;2:61ra91
   PubMed Web of Science ®Google Scholar
• Zhong XY, Holzgreve W, Hahn S. Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. Brit J Obstetr Gynaecol 2000;107:766–9
   Google Scholar
• Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Ann Rev Pathol 2010;5:173–92
   PubMed Web of Science ®Google Scholar
• Harlow FH, Brown MA. The diversity of diagnoses of preeclampsia. Hypertens Pregnancy 2001;20:57–67
   PubMed Web of Science ®Google Scholar
• Hahn S, Rusterholz C, Hosli I, Lapaire O. Cell-free nucleic acids as potential markers for preeclampsia. Placenta 2011;32:S17–20
   PubMedGoogle Scholar
• Bianchi DW. Circulating fetal DNA: its origin and diagnostic potential – a review. Placenta 2004;25:S93–101
   PubMed Web of Science ®Google Scholar
• Lo YMD, Leung TN, Tein MSC, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184–8
   PubMed Web of Science ®Google Scholar
• Leung TN, Zhang J, Lau TK, et al. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001;47:137–9
   PubMed Web of Science ®Google Scholar
• Zhong XY, Laivuori H, Livingston JC, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstetr Gynaecol 2001;184:414–19
   PubMed Web of Science ®Google Scholar
• Alberry MS, Maddocks DG, Hadi MA, et al. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstetr Gynaecol 2009;200:98.e1–e6
   PubMed Web of Science ®Google Scholar
• Molvarec A, Szarka A, Walentin S, et al. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res 2010;33:892–8
   PubMed Web of Science ®Google Scholar
• Zhong XY, Holzgreve W, Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002;21:77–83
   PubMed Web of Science ®Google Scholar
• Farina A, Sekizawa A, Iwasaki M, et al. Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat Diagn 2004;24:722–6
   PubMed Web of Science ®Google Scholar
• Hahn S, Holzgreve W. Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia. Hum Reprod Update 2002;8:501–8
   PubMed Web of Science ®Google Scholar
• Maddocks DG, Alberry MS, Attilakos G, et al. The SAFE project: towards non-invasive prenatal diagnosis. Biochem Soc Trans 2009;37:460–5
   PubMedGoogle Scholar
• Chiu RWK, Lo YMD. Noninvasive prenatal diagnosis empowered by high-throughput sequencing. Prenat Diagn 2012;32:401–6
   PubMed Web of Science ®Google Scholar
• Levine RJ, Qian C, LeShane ES, et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstetr Gynaecol 2004;190:707–13
   PubMed Web of Science ®Google Scholar
• Kleinrouweler CE, Wiegerinck MMJ, Ris-Stalpers C, et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 2012;119:778–87
   PubMed Web of Science ®Google Scholar
• Barrett AN, Zimmermann BG, Wang D, et al. Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield. Plos One 2011;6:e25202
   PubMed Web of Science ®Google Scholar
• Bianchi DW. Fetal cells in the maternal circulation: feasibility for prenatal diagnosis. Brit J Haematol 1999;105:574–83
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996;93:705–8
   PubMed Web of Science ®Google Scholar
• Byrne BM, Crowley A, Taulo F, et al. Fetal DNA quantitation in peripheral blood is not useful as a marker of disease severity in women with preeclampsia. Hypertens Pregnancy 2003;22:157–64
   Web of Science ®Google Scholar
• Cotter AM, Martin CM, O’Leary JJ, Daly SF. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia. Am J Obstet Gynecol 2004;191:515–20
   PubMed Web of Science ®Google Scholar
• VanGuilder HD, Vrana KE, Freeman WM. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 2008;44:619–26
   PubMed Web of Science ®Google Scholar
• Zimmermann BG, Holzgreve W, Avent N, Hahn SH. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. In: Swaminathan R, Butt A, Gahan P, eds. Circulating nucleic acids in plasma and serum IV. Vol 1075. Oxford: Blackwell Publishing; 2006:347–9
   Google Scholar
• Tang NLS, Leung TN, Zhang J, et al. Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clin Chem 1999;45:2033–5
   PubMed Web of Science ®Google Scholar
• Zhao FX, Wang JA, Liu RH, et al. Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma. Prenat Diagn 2010;30:778–82
   PubMed Web of Science ®Google Scholar
• Platts AE, Johnson GD, Linnemann AK, Krawetz SA. Real-time PCR quantification using a variable reaction efficiency model. Analytical Biochem 2008;380:315–22
   PubMed Web of Science ®Google Scholar
• Lo YMD. Non-invasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA. Open Biol 2012;2:120086. doi: 10.1098/rsob.120086
   PubMedGoogle Scholar
• Kinde I, Papadopoulos N, Kinzler KW, Vogelstein B. FAST-SeqS: a simple and efficient method for the detection of aneuploidy by massively parallel sequencing. Plos One 2012;7:e41162
   PubMed Web of Science ®Google Scholar
• Leung TN, Zhang J, Lau TK, et al. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001;47:137–9
   PubMed Web of Science ®Google Scholar
• Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005;15:475–82
   PubMed Web of Science ®Google Scholar
• Lazar L, Rigo J, Jr Nagy B, et al. Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med Genet 2009;10:120
   Google Scholar
• Gerovassili A, Garner C, Nicolaides KH, et al. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? Prenat Diagn 2007;27:104–10
   PubMed Web of Science ®Google Scholar
• Lapaire O, Volgmann T, Grill S, et al. Significant correlation between maternal body mass index at delivery and in the second trimester, and second trimester circulating total cell-free DNA levels. Reprod Sci 2009;16:274–9
   PubMed Web of Science ®Google Scholar
• Haghiac M, Vora NL, Basu S, et al. Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity (Silver Spring) 2012;20:2213–19
   PubMed Web of Science ®Google Scholar
• Lo YM, Lau TK, Zhang J, et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 1999;45:1747–51
   PubMed Web of Science ®Google Scholar
• Lazar L, Nagy B, Ban Z, et al. Presence of cell-free fetal DNA in plasma of women with ectopic pregnancies. Clin Chem 2006;52:1599–601
   PubMed Web of Science ®Google Scholar
• Lasabova Z, Zigo I, Svecova I, et al. Association of specific diplotypes defined by common rs1800682 and rare rs34995925 single nucleotide polymorphisms within the STAT1 transcription binding site of the FAS gene promoter with preeclampsia. Gen Physiol Biophys 2014;33:199–204
   Google Scholar
• Hristoskova S, Holzgreve W, Hahn S. Anti-phospholipid and anti-DNA antibodies are not associated with the elevated release of circulatory fetal DNA in pregnancies affected by preeclampsia. Hypertens Pregnancy 2004;23:257–68
   PubMed Web of Science ®Google Scholar
• Karina E, Tomasz P, Bilar M, et al. Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator – preliminary report. Eur J Obstet Gynecol Reprod Biol 2009;146:165–8
   Google Scholar
• Farina A, Sekizawa A, Rizzo N, et al. Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood. Prenat Diagn 2004;24:293–7
   PubMed Web of Science ®Google Scholar
• Zhong XY, Wang Y, Chen S, et al. Circulating fetal DNA in maternal plasma is increased in pregnancies at high altitude and is further enhanced by preeclampsia. Clin Chem 2004;50:2403–5
   Google Scholar
• Lau TW, Leung TN, Chan LY, et al. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002;48:2141–6
   PubMed Web of Science ®Google Scholar
• Farina A, Sekizawa A, Sugito Y, et al. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn 2004;24:83–6
   PubMed Web of Science ®Google Scholar
• Sifakis S, Zaravinos A, Maiz N, et al. First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol 2009;201:472.e1–e7
   PubMed Web of Science ®Google Scholar
• Swinkels DW, de Kok JB, Hendriks JC, et al. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002;48:650–3
   PubMed Web of Science ®Google Scholar
• Illanes S, Parra M, Serra R, et al. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat Diagn 2009;29:1118–22
   PubMed Web of Science ®Google Scholar
• Lo YM, Leung TN, Tein MS, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184–8
   PubMed Web of Science ®Google Scholar
• Engel K, Plonka T, Bilar M, et al. The analysis of the correlation between extracellular fetal DNA concentration in maternal circulation and severity of preeclampsia. Ann Acad Med Stetin 2007;53:20–5
   PubMedGoogle Scholar
• Levine RJ, Qian C, Leshane ES, et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004;190:707–13
   PubMed Web of Science ®Google Scholar
• Sekizawa A, Jimbo M, Saito H, et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstetr Gynaecol 2003;188:480–4
   PubMed Web of Science ®Google Scholar
• Smid M, Galbiati S, Lojacono A, et al. Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies. Prenat Diagn 2006;26:785–90
   PubMed Web of Science ®Google Scholar